![Donald Bergstrom](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Donald Bergstrom
Teknisk/Vetenskaplig/F&U Direktör på
RELAY THERAPEUTICS, INC.
Förmögenhet: 6 M $ per 2026-05-31
Profil
Donald A. Bergstrom is currently an Independent Director at Cellectis SA since 2022, a Director at Cellectis, Inc., and President-Research & Development at Relay Therapeutics, Inc. since 2018.
Formerly, Dr. Bergstrom was an Independent Director at Fusion Pharmaceuticals, Inc. from 2021 to 2024, Chief Medical Officer & Senior Vice President at Mersana Therapeutics, Inc. from 2014 to 2018, Global Head-Translational & Experimental Medicine at Sanofi-Aventis U.S.
LLC from 2010 to 2014, Principal at Merck Research Laboratories Massachusetts LLC, and Global Head-Translational Medicine at Genzyme Therapeutics Ltd. from 2010 to 2014.
Education includes a doctorate from the University of Washington and an undergraduate degree from The Johns Hopkins University.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
RELAY THERAPEUTICS, INC. 0,22 % | 2026-04-28 | 418 557 ( 0,22 % ) | 6 M $ | 2026-05-31 |
Aktiva positioner av Donald Bergstrom
| Företag | Position | Start |
|---|---|---|
| RELAY THERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2018-04-01 |
| CELLECTIS S.A. | Direktör/Styrelseledamot | 2022-06-28 |
Cellectis, Inc.
 Cellectis, Inc. Pharmaceuticals: MajorHealth Technology Engages in the upstream research of genome engineering and in the development of pre-engineered products for pharmaceutical industry, cell therapies, seed companies, and laboratory researchers | Direktör/Styrelseledamot | - |
Tidigare kända positioner av Donald Bergstrom
| Företag | Position | Slut |
|---|---|---|
| FUSN PHAR | Direktör/Styrelseledamot | 2024-06-04 |
| MERSANA THERAPEUTICS | Teknisk/Vetenskaplig/F&U Direktör | 2018-03-31 |
Sanofi-Aventis U.S. LLC
 Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Develops medicines, vaccines and provides specialized healthcare & clinical trail services | Företagsledare/Principal | 2014-01-01 |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for patients affected by rare and debilitating diseases | Företagsledare/Principal | 2014-01-01 |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Företagsledare/Principal | - |
Donald Bergstroms utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
34
Första gradens relationer
10
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 10 |
|---|---|
Mersana Therapeutics, Inc.
 Mersana Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures antibody drug conjugates to improve patient outcomes in multiple oncology indications | Health Technology |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cellectis SA
 Cellectis SA Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops immunotherapies | Health Technology |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Develops medicines, vaccines and provides specialized healthcare & clinical trail services | Health Technology |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for patients affected by rare and debilitating diseases | Health Technology |
Cellectis, Inc.
Cellectis, Inc. Pharmaceuticals: MajorHealth Technology Engages in the upstream research of genome engineering and in the development of pre-engineered products for pharmaceutical industry, cell therapies, seed companies, and laboratory researchers | Health Technology |
Relay Therapeutics, Inc.
 Relay Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage precision medicine company, which focus on enhancing small molecule therapeutic discovery in targeted oncology | Health Technology |
Fusion Pharmaceuticals, Inc.
 Fusion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company developing next-generation radiopharmaceuticals for the treatment of cancer | Health Technology |
